UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

Breast (Edinburgh), 2022-02, Vol.61, p.77-83

2022

Volltextzugriff (PDF)

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

CA: a cancer journal for clinicians, 2021-01, Vol.71 (1), p.78-92

2021

Volltextzugriff (PDF)

Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer

Journal of clinical oncology, 2021-02, Vol.39 (6), p.608-618

2021

Volltextzugriff (PDF)

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors

Cancer, 2017-04, Vol.123 (7), p.1249-1258

2017

Volltextzugriff (PDF)

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Journal of the American Geriatrics Society (JAGS), 2019-05, Vol.67 (5), p.920-927

2019

Volltextzugriff (PDF)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Breast cancer research : BCR, 2020-11, Vol.22 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer

Journal of clinical oncology, 2009-02, Vol.27 (5), p.713-719

2009

Volltextzugriff (PDF)

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

Annals of surgery, 2017-03, Vol.265 (3), p.581

2017

Volltextzugriff (PDF)

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

Annals of surgery, 2017-03, Vol.265 (3), p.581-589

2017

Volltextzugriff (PDF)

Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

NPJ breast cancer, 2024-04, Vol.10 (1), p.26-26, Article 26

2024

Volltextzugriff (PDF)

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013

Journal of clinical oncology, 2018-01, Vol.36 (1), p.14-24

2018

Volltextzugriff (PDF)

Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study

BMC primary care, 2023-08, Vol.24 (1), p.165-165, Article 165

2023

Volltextzugriff (PDF)

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Breast cancer research and treatment, 2017-01, Vol.161 (2), p.363-373

2017

Volltextzugriff (PDF)

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)

NPJ breast cancer, 2022-11, Vol.8 (1), p.127-9, Article 127

2022

Volltextzugriff (PDF)

State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012

JAMA surgery, 2017-07, Vol.152 (7), p.648

2017

Volltextzugriff (PDF)

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1190-1196

2016

Volltextzugriff (PDF)

Acupuncture for Chemotherapy‐Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial

The oncologist (Dayton, Ohio), 2020-04, Vol.25 (4), p.310-318

2020

Volltextzugriff (PDF)

Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status

Cancer, 2021-09, Vol.127 (18), p.3310-3324

2021

Volltextzugriff (PDF)

Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer

Clinical cancer research, 2017-06, Vol.23 (11), p.2647-2654

2017

Volltextzugriff (PDF)

Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women’s Health Initiative Trials

JAMA : the journal of the American Medical Association, 2020-07, Vol.324 (4), p.347

2020

Volltextzugriff (PDF)

Who Are the Patients in Our Clinical Trials for Cancer?

Journal of clinical oncology, 2019-06, Vol.37 (18), p.1519-1523

2019

Volltextzugriff (PDF)

Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial

JAMA surgery, 2023-06, Vol.158 (6), p.583

2023

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?

JNCI : Journal of the National Cancer Institute, 2020-06, Vol.112 (6), p.551-552

2020

Volltextzugriff (PDF)

1 – 25 von 488

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(433)
Mit Volltextzugriff
(424)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(488)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013

Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)

State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study

Acupuncture for Chemotherapy‐Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial

Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status

Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer

Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women’s Health Initiative Trials

Who Are the Patients in Our Clinical Trials for Cancer?

Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial

Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?

Suchergebnisse filtern